Drug Negotiation Episodes
Oct. 12, 2023
Coverage with Evidence Development
Kirsten Axelsen, Senior Policy Advisor with global law firm DLA Piper, explains what Coverage with Evidence Development is and how it restricts patients access; the manufacturers of all 10 of the first drugs announced for Me…
None